XML 95 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Equity (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights
The following table summarizes warrant activity for the years ended December 31, 2019, 2018 and 2017 as follows:
 
Number of Warrants
 
 
 
Equity classified
Liability classified
Total
 
Weighted average
exercise price
Outstanding at December 31, 2017
176,432


176,432

 
$
17.32

Issuance



 

Exercises



 

Expirations/ cancellations
(80,813
)

(80,813
)
 
17.55

Outstanding at December 31, 2018
95,619


95,619

 
17.12

Issuance
8,342,128

22,988,501

31,330,629

 
1.07

Exercises



 

Expirations/ cancellations



 

Outstanding at December 31, 2019
8,437,747

22,988,501

31,426,248

 
$
1.12


Schedule of Authorized Shares of Common Stock for Future Issuance The Company has authorized shares of common stock for future issuance as follows:
 
Period ending
 
December 31, 2019
 
December 31, 2018
Exercise of common and pre-funded warrants
31,426,248

 
95,619

Shares available for future stock incentive awards
1,765,018

 
1,586,925

Unvested restricted stock units
181,250

 
175,000

Outstanding common stock options
6,796,669

 
4,093,979

Total
40,169,185


5,951,523